-
3:00 PM – 4:00 PMP01 – Department of Corrections: Bringing It To The MAT
Angela Bonaguidi, LCSW, LAC, MAC, MSWCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP02 – Effectively Reducing Stigma and increasing access to care in the Community.
Allie V. Severino – Fresh Start InitiativeCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP03 – Improving the Continuum of Care: Overview of a Peer-Operated Warm Line to Address the Opioid Epidemic
Dawn Farrell-Moore, LCSW – Richmond Behavioral Health Authority; Lauren Stevens, LCSW – Richmond Behavioral Health Authority; Neal Masri, Ph.D. – Richmond Behavioral Health AuthorityCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP04 – Michigan Re-Entry Project: Wraparound Services and Medication Assisted Treatment for Returning Citizens
Emily Pasman, LLMSW – Wayne State University Center for Behavioral Health and JusticeCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP05 – Pharmacists Taking Action: Screening Patients for Opioid Misuse and Accidental Overdose Within Community Pharmacies
Heidi Eukel, PharmD – North Dakota State UniversityCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP07 – Changes in the Prevalence of Methamphetamine Abuse among Individuals Entering Medication-Assisted Treatment Programs
Karin McBride, M.A. – Denver Health, Rocky Mountain Poison & Drug Center – RADARS® System; S. Geoff Severtson, PhD – Denver Health, Rocky Mountain Poison & Drug Center – RADARS SystemOpioid Abuse as a Public Health Crisis and Overdose as an Epidemic
-
3:00 PM – 4:00 PMP08 – Collaboration between Public Health and MAT in the Treatment of Hepatitis C
Jacqueline Martin, MS in Psychology Evaluation, Research, and Measurement; Brian Goodlett, MA – New Mexico Treatment ServicesOpioid Abuse as a Public Health Crisis and Overdose as an Epidemic
-
3:00 PM – 4:00 PMP10 – Opioid Use, Prior Substance Use Treatment, and Age at First Use: Clients Discharged at a NYC Treatment Provider in 2018
Olivia Charles, MPH – Samaritan Daytop VillageOpioid Abuse as a Public Health Crisis and Overdose as an Epidemic
-
3:00 PM – 4:00 PMP12 – Atomoxetine and Methylphenidate in the treatment of cocaine use disorder in heroin use disorder patients with concomitant adult ADHD
Giada CipollonePatient Care & Best Practices
-
3:00 PM – 4:00 PMP13 – Awareness and willingness for uptake of Pre-exposure prophylaxis among people who use drugs (PWUD) in Ngara Methadone Clinic (MAT) Nairobi, Kenya
Brenda Mogaka, Dr – Nairobi City County Methadone ClinicPatient Care & Best Practices
-
3:00 PM – 4:00 PMP14 – Emerging from the shadows: Hearing the Patient Voice
Sonya J. Lockyer, MBA – Canadian Addiction Treatment Centres; Kate Johnston, BA – Canadian Addiction Treatment Centres; David C. Marsh, MD – Canadian Addiction Treatment CentresPatient Care & Best Practices
-
3:00 PM – 4:00 PMP15 – Further evidence of a psychopathology specific to heroin use disorder. Psychopathological dimensions and addictive behaviours: relationships
Filippo Della Rocca, Resident in Psychiatry – University of Pisa, Clinica psichiatrica Santa ChiaraPatient Care & Best Practices
-
3:00 PM – 4:00 PMP16 – Getting to Stable: Do Early Peak Dose Evaluations Enhance Patient Stability?
James E. Anderson, PA-C – Evergreen Treatment ServicesPatient Care & Best Practices
-
3:00 PM – 4:00 PMP17 – Impact of Co-morbid Cocaine Use on Maternal and Infant Outcomes among Pregnant Women Receiving Medication Assisted Treatment
Mellissa Giegerich, BS (MSW research assistant); Michelle Tuten, PhDPatient Care & Best Practices
-
3:00 PM – 4:00 PMP18 – Improving Engagement and Retention by Initiating Treatment with Methadone for Opioid Use Disorder in an Inpatient Rehabilitation Setting
Gloria Baciewicz, MD – Strong RecoveryPatient Care & Best Practices
-
3:00 PM – 4:00 PMP19 – Occupational Therapy Treatment Techniques used Concurrently with MAT for the Management of Pain Associated with OUD
Pat Precin, PhD, PsyaD. OTR/L, LP, NCPsyA – Columbia UniversityPatient Care & Best Practices
-
3:00 PM – 4:00 PMP20 – Practical Tools for Treating Opioid Use Disorders among Individuals in Custody
Niki A. Miller, MS, CPS – Advocates for Human Potential, Inc.; Andrew Klein, PhD – Advocates for Human Potential, Inc.Patient Care & Best Practices
-
3:00 PM – 4:00 PMP21 – Reasons for starting and stopping medications for opioid use disorder: a qualitative analysis
Barbara Andraka-Christou, J.D., PhD – University of Central FloridaPatient Care & Best Practices
-
3:00 PM – 4:00 PMP22 – Same Day Access to Buprenorphine for Veterans with Opioid Use Disorders
Sara Chaudhry, LICSW – VA Puget Sound Health Care System; Sergio Flores, PsyD – VA Puget Sound Health Care System; Tory A. Durham, PhD – VA Puget Sound, SeattlePatient Care & Best Practices
-
3:00 PM – 4:00 PMP23 – Successfully Engaging People with Substance Dependence and Hepatitis and/or Human Immunodeficiency Virus into Medical Treatment.
Despina Vougioukas, CRC – Lower Eastside Service Center; Joe Krasnansky, LCSW-R – Lower Eastside Service CenterPatient Care & Best Practices
-
3:00 PM – 4:00 PMP24 – Integrating the Community Pharmacist in Upstream Prevention of Opioid Misuse and Accidental Overdose
Amy Werremeyer, PharmD – North Dakota State University; Heidi Eukel, PharmD – North Dakota State UniversityWorkforce Development
-
3:00 PM – 4:00 PMP25 – Linguistic Bias and Stigma Among Individuals in Substance Use Disorder Recovery and the Health Professionals Who Treat Them
Robert D. Ashford, MSW – Substance Use Disorders Institute, University of the sciences; Gail G. Scott, MPH – University of the Sciences; Andrew Peterson, PharmD PhD – Substance Use Disorders Institute, University of the SciencesWorkforce Development
Available Pages
- #9287 (no title)
- #10171 (no title)
- “How To” Webinar
- #2019aatod Conference Wrap-up
- #Blacklivesmatter
- 1 – State Actions to Support Provider Innovation: Statutory, Regulatory and Administrative Reform
- 1998 Methadone Maintenance Program and Patient Census in the U.S.
- 2 – When Disaster Strikes: Partnerships and Strategies for a Coordinated Response to Hurricane Florence
- 2016 Awards Program
- 2016 Conference Photos
- 2019 Award Recipients
- 2019 Continuing Education Credits
- 2019 Disclosure of Financial Interests
- 2019 Exhibit Information
- 2019 Sponsors
- 2019 World Disney World
- 2022 Awards
- 2022 Conference Albums
- 2022 Conference Sponsors
- 2022 Continuing Education Credits
- 2022 Workshop Sessions
- 3 – Claims Trends and Risk Management in an Increasingly Litigious World
- A1 – Foundations of Medication Assisted Treatment
- A2 – The Criminal Justice System: An Effective Access Point To Treating Opioid Addiction
- A3 – Community Engagement Workshop for Opioid Treatment Programs
- A4 – Practical Methods to Increase Retention in Medication Assisted Treatment
- A5 – A Clinical Conundrum: Pain, Addiction or Both
- AATOD Awards Banquet
- AATOD Conference
- AATOD Guidelines for Guest Medication
- AATOD Guidelines for Using Naltrexone (Vivitrol) in OTPs
- AATOD Homepage
- AATOD Homepage – Testing Page Only
- AATOD PDMP Policy Guidance Statement for OTPs
- AATOD’s 5-Year Plan (2012 – 2016)
- AATOD’s Five Year Plan
- AATOD’s Response to SAMHSA’s Federal Register Notice of May 16, 2013 in Updating the Accreditation Guidelines for OTPs
- AATOD’s Project Update: Opioid Use Study
- Abigail Kay, MD
- About Baltimore
- About Us
- Accreditation
- Activity
- Addressing Benzodiazepine Use in OTPs
- Advocacy
- Akiva Daum, MD
- Alan Nolan, LCSW
- Alexander Kantchelov, MD
- Alf Martin M. Haraldsen, MD
- Alice Fischer
- Allegra Schorr
- Allegra Schorr, MA
- Allie V. Severino
- Amanda Gordon, MS, CACIII
- Amy Morris
- Amy Werremeyer, PharmD
- Anahi Ortiz, M.D.
- Andrej Kastelic, PhD
- Andrew H. Talal, MD, MPH
- Andrew Klein, PhD
- Andrew Peterson, PharmD PhD
- Angela Bonaguidi, LCSW, LAC, MAC, MSW
- Angela Mason, MPH, BSN, RN
- Angelo G.I. Maremmani, MD
- Anita R. Kennedy, CRPA CMA
- Ann Jamieson, MS, LADC
- Anna M. Munoa, MD
- Anne Kelly
- Association Expands Its Training Course to Physicians and Clinicians in Methadone Treatment Programs
- Association Introduces Management Training Symposia
- Association Survey Identifies Greater Numbers in Methadone Treatment
- B1
- B2
- B3
- B4
- B5
- Barbara Andraka-Christou, J.D., PhD
- Belinda Greenfield, PhD
- Blogs
- Board Member Login Area
- Bobby Brown
- Bradley J. Bertrand, CAC III
- Brenda Davis, CMSW
- Brenda Davis, MSW
- Brenda Mogaka, Dr
- Brent Gibson, MD, MPH, FACPM, CCHP-P
- Brian Crissman
- Brian Goodlett, MA
- Brian McCarroll, DO
- Brian McCarroll, M.S., D.O.
- Brief Historical Background
- Brooke M. Feldman, MSW
- Buprenorphine and the Use of Clinically Effective Medications in Treating Chronic Opiate Dependence
- C1
- C2
- C3
- C4
- C5
- Canon of Ethics
- Carol Cruz, CRC
- Caroline Waterman, LRC, MA,CRC
- Challenges and Opportunities
- Chasing Heroin Documentary
- Cheryl Gardine, LCSW
- Chimera Award Recipients
- Chio Ramirez, CAC III
- Christine Atkin
- Christine Khaikin, JD
- Christine L. Florio, LPC
- Christine Martin, M.A., LMFT
- Christine Roussel, PharmD
- Claude D. Hopkins, Jr., CADC CMA
- Clinic Tours
- Closing Plenary Session
- CME Chart
- CMS-1770-P
- Colleen Dobo, Psy.D.
- Colleen LaBelle, MSN, RN-BC CARN
- Colorado Medical Director Rule
- Conclusion
- Conference App
- Conference Center
- Conference Development/Training
- Conference Newsletter – Edition No. 6
- Conference Opening October 19 – 20, 2019
- Conference Videos
- Confidentiality and MAT
- Connecticut’s Mobile Medication Assisted Treatment
- Connecting Justice with Treatment – Part 1
- Contribute by Mail
- Corey Love, LMHC
- COVID – 19: State Policy Guidance
- COVID-19
- COVID-19: AATOD’s Guidance for OTPs
- Criminal Justice
- D1
- D2
- D3
- D4
- D5
- Dave Kneessy, MS, LMHC
- David C. Marsh, MD
- David Gagliardi
- Dawn Farrell-Moore, LCSW
- Dayan Colon Sanchez, MD
- Deborah Witham, MSW, JD
- Declan Barry, PhD
- Dennis M. Lemma, Masters
- Despina Vougioukas, CRC
- Developing Educational Initiatives for Members of Congress
- Diane J. Abatemarco, Phd, MSW
- Dinita Smith, MSW, LCADC
- Dinita Smith, MSW, LCADC
- Dispensing Methadone Through Pharmacies
- Donate Online
- Donetta Spears
- Donors
- Douglas T. Dieterich, MD
- Dr. Luis Patricio’s Video Presentation
- Drug Addiction and Treatment Act (S.324) (H.R.2634)
- Dual Disorders
- Dustin M. Alvanas, MBA
- E1
- E2
- E3
- E4
- E5
- Early Findings about Patient/Staff Infection Rate
- Emily Hosea, M.Ed, NCC
- Emily Pasman, LLMSW
- Erin LaCourt
- Evelyn Reinhardt, BSW, MSB
- Expanding Access to MAT in Correctional Settings
- Expanding Access to Medical Maintenance Treatment
- Expanding the Footprint of OTPs in United States
- Expanding the Footprint of OTPs in United States
- Expanding the Use of Mobile Vans
- F1
- Featured News
- Filippo Della Rocca
- First Key Question About Addiction
- Five – Year Plan (2022 – 2026)
- Florida Judges and Court Staff Session (Closed Session)
- Forum
- Four Practical Guidelines for Treatment
- Francesco Lamanna, MD
- Frederick Muench, PhD
- Funding
- Funding
- G. Davy Kneessy, MS, MAC, MCAP, LMHC
- Gabrielle R. de la Gueronniere, J.D./Law
- Gail G. Scott, MPH
- General Barry R. McCaffrey, United States Army
- Giada Cipollone
- Gilberto Gerra, MD
- Gina Florenzano, LPC
- Give
- Gloria Baciewicz, MD
- Grant Mitchell, MD
- Guidance to OTPs Concerning the Use of Prescription Monitoring Program (PMP) Database
- Hani Members, RPA-C
- Heidi Eukel, PharmD
- Holly Broce, MHA, LCADC
- Holly N. Hagle, PhD
- Hope Bristol
- Hot Table Round Table No. 1
- Hot Topic Roundtable No.
- Hot Topic Roundtable No. 2
- Hot Topic Roundtable No. 3
- How Methadone Works
- Howard Ashkin, MMH
- Icro Maremmani, MD
- Imminent Changes in Our Field
- In Memoriam of Kate Mahoney
- In the News
- Increased Access to Interim Care through an OTP
- Increasing Access to Medications
- Increasing Support For Treatment in the Medical Establishment
- Increasing the Number of OTPs and Patients in the United States
- Indiana Community Mental Health Center
- Individual Membership
- Individual Membership File Sharing Area
- International Work
- International Work
- Introduction
- Introduction
- Introduction
- Jacqueline Martin, MS
- James E. Anderson, PA-C
- Janice F. Kauffman, R.N., M.P.H. C.A.S.
- Jason Kletter, Ph.D.
- Jean Thomas, PA
- Jeffrey Greenblatt, MA, LADC
- Jeri Cohen, JD
- Joe Krasnansky, LCSW-R
- John Brooklyn, MD
- John Hamilton, LMFT, LADC
- John Koch, CPSS
- John Renner, MD
- Jonathan Ciampi
- Joshua D. Nirella, MSO
- Joycelyn S. Woods, MS, CMA
- Julia Finken, BSN, MBA, CPHQ, CSSBB
- Karin McBride, M.A.
- Kate Johnston, BA
- Kate Mahoney, LCSW
- Katharina L. Wiest, PhD
- Kathleen Maurer, MD
- Kathleen Rebbert-Franklin, LCSW-C
- Keith Raskin, LMHC
- Kellie Rollins, PsyD
- Kelly Steele, MS
- Kenneth B. Stoller, MD
- Kenneth L. Miller, PhD
- Kenneth Stoller, M.D.
- Kenny House, LCAS, CCS
- Kevin Fiscella, MD, MPH, CCHP
- Kimberly Jones
- Klaus Nether
- Krista Mayes
- Laura F. McNicholas, MD, PhD
- Lauren Siembab, MS, LADC
- Lauren Stevens, LCSW
- Laurie Krom, MS
- Leslie Bridgman, MA, JD, LCDP
- Linda Hurley, MA CAGS
- Lisa Gawenus, FACHE
- Livia M. Davis, MSW
- Long-acting Opioid Agonist Medications: Research and Clinical Practice
- Lynn M. Madden, PhD
- Marc Auriacombe, MD
- Marc Schlosser, MD
- Margaret B. Rizzo
- Margie Donohue
- Mark Fontaine
- Mark Kraus, MD.
- Mark Parrino
- Mark W. Parrino, M.P.A.
- Mary Walton
- MAT for Opioid Addiction in the Criminal Justice System
- MAT for Opioid Use Disorder in the Justice System
- MAT Waiver Training
- MAT: Challenges and Solutions
- Maxine M. Fuller, M.S.
- Media
- Medication Assisted Treatment & Neuroplasticity
- Medication-Assisted Treatment for Opioid Use Disorders
- Megan Marx-Varela, MPA
- Mellissa Giegerich, BS
- Members
- Membership Application
- Membership Application Form
- Message from Mike Rizzi
- Methadone Treatment: Our Vision for the Future
- Michael McKinney, LMSW
- Michael Rizzi
- Michelle Gaffaney, PA-C
- Michelle R. Lofwall, MD
- Michelle Tuten, PhD
- Middle Plenary Session
- Missouri’s Effort to Expand Accèss to MAT to Incarcerated
- Misty Challinor
- Mobile Vans
- Mobile Vans
- Molly Carney, PhD, MBA
- Monday, October 21, 2019 – Photo Gallery
- Moving Forward with Innovative Change
- Narcotic Treatment Programs Best Practice Guidelines
- Neal Masri, Ph.D.
- Neurobiology of Heroin Addiction and of Methadone Treatment
- New Jersey Passes Law
- New Support for Methadone Maintenance Treatment through a Realistic National Drug Policy
- New York State Advocates Seek Legislation
- News From the Front
- Nick Stavros
- Niki A. Miller, MS, CPS
- Non-Mobile Van Units
- Notice for Proposed Rule Making – Change in Federal Oversight for Methadone Treatment
- Nusa Segrec, MD, PhD
- Olivia Charles, MPH
- Olivia Randall-Kosich
- Opioid Addiction Treatments That May Surface in 2018
- Opioid Education
- Opioid Maintenance Pharmacotherapy: A Course for Clinicians (Registration Required)
- Pamela M. Morrison, LPA, LCAS, CCS
- Passing of the Baton…Baltimore 2022
- Pat Precin, PhD, PsyaD. OTR/L, LP, NCPsyA
- Patient Recognition Ceremony
- Paul Bowman, CMA
- Paul Samuels, JD
- Peter Krajci, MD, PhD
- Peter Vossenberg, MD
- Petra Jacobs, MD
- Plenary 1
- Policy For Treating Methadone Maintained Patients in Private Medical Settings
- Poster Sessions
- Presentations by the World Federation for the Treatment of Opioid Dependence
- Press Release – April 22, 2021
- Press Release, HHS / SAMHSA Releases New OTP Regulations
- Press Releases
- Program Membership
- Progress Report
- Progress Report
- Prologue
- Proposal to Increase Medicaid Utilization for OTPs
- Rachel Chernick, LCSW
- Ray Caesar, LPC
- Recommendations for Hepatitis Prevention and Treatment
- Recommendations in Siting New OTPs
- Recommendations
- Recommended Changes in Federal and State Oversight for OTPs
- References
- Reginald Whitehead, JD
- Regulatory Reform
- Report from Italy
- Reports from the States
- Rhode Island Model of MOUD in Corrections Withstands COVID…
- Richard Bilangi, M.S.
- Rick Scott
- Ricky Morris
- Robert C. Lambert, MA, LADC
- Robert C. Sherrick, MD, FASAM
- Robert D. Ashford, MSW
- Robert Kent
- Robert Lambert, MA
- Rochelle Head-Dunham, MD, FAPA
- Rosemarie Martin, PhD
- Roye T. Brown, M.S., LAC, CCS
- S. Geoff Severtson, PhD
- Sandy Neidert, MSW
- Sara Chaudhry, LICSW
- Sara Lorenz Taki, MD
- Satellite Medication Units
- Second Key Question About Addiction
- Seniors Face Barrier for Common Opioid Addiction Treatment
- Sergio Flores, PsyD
- Sharel Rogers
- Sharon Dow, MS
- Sonya J. Lockyer, MBA
- Sponsorship
- Spread the Word
- Stacey Pearce
- State Membership
- Stephanie Cardoos, PhD
- Stephen Maulhardt, CPA
- Stevan A. Gonzalez, MD, MS
- Steven H. Smith, LPCC-S, LICDC-CS
- Support
- Surendra B. Adhikari, PhD MedSoc
- Susan Case MS, ED.S., LPC
- Telehealth Services Through OTPs
- Telehealth Services Through OTPs
- Testimonials
- The Certified Medication Assisted Treatment Advocate (CMA) Training Course (Registration Required)
- The Combined COVID-19 Pandemic and Opioid Use
- The Combined COVID-19 Pandemic and Opioid Use Epidemic
- The Impact of COVID-19 on OTPs
- Thomas A. Hedrick, Jr., BS
- Thomas Clausen, MD, PhD
- Tina Beckley, M.A., CACII
- Tina Braham, LMSW
- Tory A. Durham, PhD
- Tracey Nicolosi, LMHC
- Transforming Care Delivery: High Reliability in Medication Assisted Treatment
- Triple E for HCV Engagement Education and Eradication
- Tuesday, October 22, 2019 – Photo Gallery
- Ultra Rapid Detoxification
- Ute Gazioch
- Utilization of Medications in Correctional Settings
- Victor Nevarez
- Walter Ginter, CMA
- Walter Ling, MD
- Washington State Prescription Monitoring Program
- Webinar
- Webinar Development, Enhanced Communication
- Wednesday, October 23, 2019 – Photo Gallery
- Welcome to AATOD’s 2021 Virtual Conference
- Welcome! #aatod2019
- Wendy Looker, RN, BS
- Workforce Shortages and Development
- Working with Denver Health and Hospital Authority/RADARS® System
- Yngvild Olsen, MD, MPH
- Zachary C. Talbott, CCS
- 2018 AATOD Conference: New York
- Addiction, Prevention, Treatment, Recovery
- Dr. Luis Patricio’s Video Presentation
- Guide to Integrating HCV Services into OTPs
- Membership Categories & Benefits
- Our Story
- Policy Statements
- Toolkits
- 2016 AATOD Conference: Baltimore
- AATOD Hill Day
- AATOD Newsletters
- Advertise With Us
- Opioid Treatment Provider Locator
- Our Activities
- Prescription Opioids
- Whitepapers
- 2015 AATOD Conference: Atlanta
- AATOD Fact Sheets
- Become a Member
- Members Only
- Message from Our Founder
- PCCS-M
- Research Data and Statistics
- Attend our Conference
- Criminal Justice
- Frequently Asked Questions
- Legislative Activity
- Our Board of Directors
- Philadelphia 2013
- 2012 AATOD Conference: Las Vegas
- Get Involved
- Glossary
- Join a State Chapter
- Our Team
- 2010 AATOD Conference – Chicago
- Social Media
- Suggested Publications
- 2006 AATOD Conference – Atlanta
- Video Clips
- 2004 AATOD Conference – Orlando, Florida
- 2018 AATOD Conference
- Archives
- 2021 Las Vegas
- Patient Success Stories
- Awards and Scholarships
- Conference Archive
- Conference Gallery
- Useful Links
- 2009 AATOD Conference – New York, New York
- Additional Resources